| RS2522807898 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522808002 |
KDM6A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2522808756 |
DNAAF6
|
Health Risk |
Likely pathogenic |
Ciliary dyskinesia, primary |
| RS2522808827 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522808874 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522811516 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2522812173 |
ESPN
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2522814526 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522814882 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522814914 |
SH2D1A
|
Health Risk |
Likely pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522815020 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522816970 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522817085 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522817745 |
GNB1
|
Health Risk |
Pathogenic |
— |
| RS2522818191 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522818414 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522818894 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522818944 |
SH2D1A
|
Health Risk |
Likely pathogenic |
— |
| RS2522819003 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522819045 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522819771 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522819783 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522819881 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522819978 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522820086 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522820123 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522820330 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522820794 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522820797 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522820995 |
FAAH
|
Health Risk |
Likely pathogenic |
Polysubstance abuse, susceptibility to |
| RS2522822079 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522824447 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522824468 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522824693 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522826741 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522826772 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522826850 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522826859 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522827017 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522827076 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522827131 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522827461 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522827904 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522828214 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522828488 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522828917 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522831501 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522832906 |
BCORL1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2522833971 |
KDM6A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2522834464 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522835100 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522835468 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522845145 |
OGT
|
Health Risk |
Likely pathogenic |
— |
| RS2522845856 |
OGT
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 106 |
| RS2522849913 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522849935 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522850255 |
PHKA1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS2522850390 |
PLOD1
|
Health Risk |
Likely pathogenic |
PLOD1-related disorder, Ehlers-Danlos syndrome |
| RS2522852329 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522852699 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522854199 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522854585 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522854600 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522854675 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522857207 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522857846 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS2522861951 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522862242 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522862314 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522866049 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522869732 |
OGT
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 106 |
| RS2522873347 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522874590 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2522874604 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522874923 |
PLOD1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2522875116 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522875121 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522875386 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2522875756 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522876133 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522880559 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522881050 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2522881217 |
DOCK7
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 3, Fetal akinesia deformation sequence 3 |
| RS2522881802 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522882449 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522883183 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522884028 |
ESPN
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 36, Autosomal recessive nonsyndromic hearing loss 36 |
| RS2522884710 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522884935 |
INTS11
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with motor and language delay, ocular defects |
| RS2522885017 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522893135 |
ST3GAL3
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2522894898 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2522897537 |
MTHFR
|
Health Risk |
Likely pathogenic |
— |
| RS2522899174 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2522912867 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522913310 |
UROD
|
Health Risk |
Pathogenic |
— |
| RS2522913344 |
UROD
|
Health Risk |
Likely pathogenic |
— |
| RS2522913357 |
UROD
|
Health Risk |
Likely pathogenic |
Familial porphyria cutanea tarda, Familial porphyria cutanea tarda |
| RS2522914398 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS2522915885 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |